# Asia Pacific Brain Health Supplements Market Size, Share & Forecast, By Product Type, Customer Type & Distribution Channel, 2025-2032 --- ## Market Overview # CHAPTER 1 - Market Overview The Asia Pacific Brain Health Supplements Market operates at the intersection of nutritional supplements, preventive wellness and cognitive-performance positioning. Cognitive-health awareness is structurally significant: **57 million people (2021, global)** were living with dementia and nearly **10 million new cases occur annually**. This creates awareness around healthy brain ageing, although it does not establish supplements as treatments or dementia-prevention interventions. Supply capability is supported by sophisticated supplement manufacturing and branded-health ecosystems in Australia, Japan, China and other major markets. Blackmores alone reports manufacturing capacity of approximately **3 billion tablets and capsules annually** at its Australian facility, demonstrating the production scale available to regional brands. Manufacturing quality, formulation capabilities and ingredient traceability increasingly influence retailer access and premium positioning. Regulatory architecture varies materially across Asia Pacific. Japan differentiates Foods with Nutrient Function Claims, Foods for Specified Health Uses and Foods with Function Claims, while functional claims require defined evidence and notification pathways. India separately regulates health supplements and nutraceuticals under its food-safety framework. Consequently, claims substantiation, labelling and ingredient eligibility are core market-access capabilities rather than back-office compliance activities. Digital distribution increases category reach but also raises trust and enforcement requirements. Singapore's regulator removed **3,336 illegal health-product listings (2024)** and issued **1,471 seller warnings** during one coordinated platform operation. The strategic direction is therefore toward verified ingredients, defensible claims, transparent labelling and stronger marketplace governance, favoring brands able to combine formulation science with regulatory execution and authenticated distribution. ## KPIs at a Glance * Market Value: USD 3,791 million (2025) * Dominant Region: East Asia * Dominant Segment: Product Type, Vitamins & Minerals (fastest growing) * Total Number of Players: 10 ## Future Outlook The market is projected to expand from its 2025 base through 2032 as cognitive wellness becomes embedded within broader healthy-ageing, productivity and preventive-health spending. The model assumes continued double-digit growth through 2030, supported by product innovation in citicoline, botanical extracts, omega-based formulations, vitamins and multi-ingredient nootropic blends. India represents a particularly strong structural growth market: one published benchmark places its brain-health supplement revenue at **USD 462.9 million in 2024** and projects **USD 1,264.7 million by 2030**. By 2032, the Asia Pacific Brain Health Supplements Market is projected to reach **USD 10,024 million**, representing a modeled **14.90% CAGR during 2025-2032**. Value growth is expected to outpace underlying unit growth as clinically positioned ingredients, proprietary formulations and premium formats raise average realized revenue per purchase. Forecast risk is concentrated in scientific-evidence scrutiny, health-claim restrictions and fragmented regulation. WHO's 2026 guidance specifically does not recommend vitamins B and E, omega-3 PUFA or multivitamin/mineral supplementation for dementia-risk reduction without diagnosed deficiency, reinforcing the need for compliant wellness rather than disease-prevention positioning. --- | | | | --- | --- | | **14.90%** Forecast CAGR (2025-2032) | **$10,024 Mn** 2032 Projection | --- | | | | | | --- | --- | --- | --- | | Base Year **2025** | Historical Period **2020-2025** | Forecast Period **2025-2032** | Historical CAGR **13.00%** | ### ### CAGR Value 14.90% --- ## Scope of the Report # CHAPTER 2 - Scope of the Market * **Geographic Coverage:** Asia Pacific, including Japan, China, India, Australia, New Zealand, South Korea and Southeast Asian markets * **Historical Period:** 2020-2025 * **Base Year:** 2025 * **Forecast Period:** 2025-2032 (base year inclusive) * **Market Segments Covered:** 7 primary segmentation dimensions (Product Type, Price Tier, Customer Type, Purchase Occasion, Distribution Channel, Packaging Format, Geography) * **Companies Covered:** Top 10 key players profiled * **Currency & Units:** USD, values expressed in USD Mn/Bn ### Segmentation Data Tree * Product Type + Herbal Extracts - Ginkgo and Bacopa - Adaptogenic Botanicals + Natural Molecules - Omega-3 and Phospholipids - Citicoline and Choline Donors + Vitamins & Minerals - B-Complex and Folate - Magnesium and Antioxidant Vitamins + Multi-Ingredient Nootropic Blends - Focus and Productivity Blends - Memory and Healthy-Ageing Blends * Price Tier + Mass Market - Value Single-Ingredient - Entry Multi-Vitamin + Mid-Premium - Enhanced Botanical - Combination Cognitive Support + Premium - Patented Ingredient Formulations - High-Potency Blends + Clinical/Practitioner Grade - Practitioner-Recommended Formulas - Evidence-Led Specialty Formulas * Customer Type + Students & Young Professionals - Academic Focus Users - Early-Career Productivity Users + Working-Age Wellness Consumers - Knowledge Workers - High-Stress Professionals + Active Agers 50+ - Healthy-Ageing Consumers - Memory-Maintenance Consumers + Caregivers & Family Purchasers - Adult Children Purchasers - Household Wellness Buyers * Purchase Occasion + Daily Cognitive Maintenance - Routine Wellness - Long-Term Supplementation + Memory & Healthy Ageing - Age-Related Wellness - Memory-Support Purchasing + Focus & Productivity - Work Performance - Study Performance + Stress & Mood Support - Stress Management - Mental Wellbeing Support * Distribution Channel + Pharmacies & Drug Stores - Chain Pharmacies - Independent Pharmacies + Specialty Nutrition Retail - Supplement Specialists - Health-Food Retailers + Brand D2C E-commerce - Brand Websites - Subscription Programs + Online Marketplaces - General Marketplaces - Health and Beauty Platforms + Direct Selling - Distributor Networks - Member-Based Selling * Packaging Format + Capsules & Tablets - Standard Tablets - Vegetarian Capsules + Softgels - Omega Softgels - Lipid-Soluble Nutrient Softgels + Gummies & Chewables - Adult Gummies - Chewable Tablets + Powders & Sachets - Stick Packs - Bulk Powder Formats + Liquids - Drops - Ready-to-Consume Liquids * Geography + Japan - Tokyo Metropolitan Market - Other Japanese Prefectures + China - Tier-1 City Markets - Lower-Tier City Markets + India - Metro Markets - Tier 2/3 Markets + Australia & New Zealand - Australia - New Zealand + South Korea & Southeast Asia - South Korea - Southeast Asian Markets --- ## Market Trajectory # Asia Pacific Brain Health Supplements Market Size, Share & Forecast, By Product Type, Customer Type & Distribution Channel, 2025-2032 **Geography:** Asia Pacific | **Study Period:** 2020-2032 | **Base Year:** 2025 | **Forecast Period:** 2025-2032 The Asia Pacific Brain Health Supplements Market is modeled at **USD 3,791 million in 2025**, supported by expanding cognitive-wellness awareness, healthy-ageing demand, premium functional ingredients, and omnichannel supplement retail. The model is calibrated to a published 2024 regional revenue anchor of USD 3,265.6 million and a 2030 benchmark of USD 7,954.3 million. ## Report Metadata Summary | | | | --- | --- | | **Base Year** | 2025 | | **CAGR for Past 5 Years** | 13.00% (2020-2025) | | **Historical Period** | 2020-2025 | | **Forecast Period** | 2025-2032 | | **Forecast CAGR** | 14.90% (2025-2032) | # CHAPTER 3 - Market Size, Growth Forecast and Trends This section evaluates the historical market size, analyzes year-over-year growth dynamics, and presents forecast projections supported by market performance indicators and demand-side drivers. The model uses final consumer sell-through revenue for in-scope cognitive-wellness supplements and is calibrated to published Asia Pacific category benchmarks. ### Historical and Projected Market Size (USD Mn) | Year | Market Size (USD Mn) | | --- | --- | | 2020 | 2,058 | | 2021 | 2,284 | | 2022 | 2,535 | | 2023 | 2,865 | | 2024 | 3,266 | | 2025 | 3,791 | | 2026F | 4,399 | | 2027F | 5,103 | | 2028F | 5,920 | | 2029F | 6,867 | | 2030F | 7,954 | | 2031F | 8,928 | | 2032F | 10,024 | ### YoY Growth Rate (%) | Year | YoY Growth | | --- | --- | | 2021 | 11.0% | | 2022 | 11.0% | | 2023 | 13.0% | | 2024 | 14.0% | | 2025 | 16.1% | | 2026F | 16.0% | | 2027F | 16.0% | | 2028F | 16.0% | | 2029F | 16.0% | | 2030F | 15.8% | | 2031F | 12.2% | | 2032F | 12.3% | ### Market Value vs Volume Growth (%) | Year | Market Value Growth | Unit Volume Growth | Price/Mix Contribution | | --- | --- | --- | --- | | 2020 | - | - | - | | 2021 | 11.0% | 9.5% | 1.5 pp | | 2022 | 11.0% | 9.3% | 1.7 pp | | 2023 | 13.0% | 11.2% | 1.8 pp | | 2024 | 14.0% | 11.5% | 2.5 pp | | 2025 | 16.1% | 13.2% | 2.9 pp | | 2026F | 16.0% | 13.4% | 2.6 pp | | 2027F | 16.0% | 13.2% | 2.8 pp | | 2028F | 16.0% | 13.0% | 3.0 pp | | 2029F | 16.0% | 12.8% | 3.2 pp | | 2030F | 15.8% | 12.6% | 3.2 pp | | 2031F | 12.2% | 9.9% | 2.3 pp | | 2032F | 12.3% | 9.8% | 2.5 pp | ### Historical Market Performance (2020-2025) Historical growth accelerated progressively from **11.0% in 2021** to **16.1% in 2025**, producing a five-year CAGR of 13.00%. The inflection after 2022 reflects stronger preventive-wellness spending, product premiumization and growing digital discovery. The 2024 modeled value is aligned with the independently published regional benchmark of USD 3,265.6 million, creating a hard anchor for the historical curve rather than relying solely on retrospective extrapolation. ### Forecast Market Outlook (2025-2032) Value growth is modeled near 16% through 2030 before normalizing toward 12% as penetration broadens and the market reaches a larger base. The published 2030 regional benchmark of approximately USD 7,954 million is retained as a forecast anchor. From 2030 onward, growth increasingly depends on premium ingredient science, localized claims, online replenishment and healthy-ageing use cases rather than pure first-time adoption. The resulting 2025-2032 CAGR reconciles mathematically to **14.90%**. --- ## Market Breakdown # CHAPTER 4 - Market Breakdown The market's value trajectory is supported by expanding unit demand, a rising digital sales mix and premiumization. For CEOs and investors, the key issue is whether brands can convert cognitive-health interest into compliant repeat purchase while protecting pricing through differentiated ingredients and trusted distribution. | Year | Market Size (USD Mn) | YoY Growth (%) | Unit Volume Index (2025=100) | Online Channel Share (%) | Premium Product Share (%) | Period | | --- | --- | --- | --- | --- | --- | --- | | 2020 | 2,058 | - | 59.5 | 22% | 28.0% | Historical | | 2021 | 2,284 | 11.0% | 65.2 | 25% | 29.5% | Historical | | 2022 | 2,535 | 11.0% | 71.2 | 28% | 31.0% | Historical | | 2023 | 2,865 | 13.0% | 79.2 | 31% | 32.8% | Historical | | 2024 | 3,266 | 14.0% | 88.3 | 34% | 34.5% | Historical | | 2025 | 3,791 | 16.1% | 100.0 | 37% | 36.5% | Base Year | | 2026 | 4,399 | 16.0% | 113.4 | 40% | 38.0% | Forecast and Latest Operating KPIs | | 2027 | 5,103 | 16.0% | 128.4 | 43% | 39.5% | Forecast and Industry Outlook | | 2028 | 5,920 | 16.0% | 145.1 | 46% | 41.0% | Forecast and Industry Outlook | | 2029 | 6,867 | 16.0% | 163.6 | 49% | 42.5% | Forecast and Industry Outlook | | 2030 | 7,954 | 15.8% | 184.2 | 52% | 44.0% | Forecast and Industry Outlook | | 2031 | 8,928 | 12.2% | 202.5 | 54% | 45.5% | Forecast and Industry Outlook | | 2032 | 10,024 | 12.3% | 222.3 | 56% | 47.0% | Forecast and Industry Outlook | **KPI 1, Unit Volume Index:** **100.0 (2025, Asia Pacific model)**. Capacity is unlikely to be the binding constraint for leading manufacturers; one major Australian supplier reports capacity of roughly 3 billion tablets and capsules annually, shifting competitive advantage toward formulation, claims and route-to-market execution. **KPI 2, Online Channel Share:** **37% (2025, Asia Pacific model)**. Digital expansion broadens customer acquisition but creates governance cost: Singapore removed 3,336 illegal online health-product listings in one 2024 enforcement operation, highlighting the importance of verified sellers and platform surveillance. **KPI 3, Premium Product Share:** **36.5% (2025, Asia Pacific model)**. Premiumization is increasingly ingredient-led. Blackmores and Kirin launched cognition-support products containing Cognizin citicoline in Australia and New Zealand in 2026, demonstrating investment in branded, science-positioned functional ingredients. --- --- ## Market Segmentation # CHAPTER 5 - Market Segmentation Framework Comprehensive analysis across key dimensions providing insights into market structure, consumer preferences, and distribution patterns. | | | | | --- | --- | --- | | **No of Segments:** 7 | **Dominant Segment:** Product Type | **Fastest Growing Segment:** Distribution Channel | ### Segmentation Framework | Priority | Level-1 Segment / Taxonomy Dimension | Level-2 Sub-Segments | | --- | --- | --- | | 1 | Product Type | Herbal Extracts; Natural Molecules; Vitamins & Minerals; Multi-Ingredient Nootropic Blends | | 2 | Price Tier | Mass Market; Mid-Premium; Premium; Clinical/Practitioner Grade | | 3 | Customer Type | Students & Young Professionals; Working-Age Wellness Consumers; Active Agers 50+; Caregivers & Family Purchasers | | 4 | Purchase Occasion | Daily Cognitive Maintenance; Memory & Healthy Ageing; Focus & Productivity; Stress & Mood Support | | 5 | Distribution Channel | Pharmacies & Drug Stores; Specialty Nutrition Retail; Brand D2C E-commerce; Online Marketplaces; Direct Selling | | 6 | Packaging Format | Capsules & Tablets; Softgels; Gummies & Chewables; Powders & Sachets; Liquids | | 7 | Geography | Japan; China; India; Australia & New Zealand; South Korea & Southeast Asia | ### Key Segmentation Takeaways Comprehensive analysis across all extracted segmentation dimensions providing insights into market structure, consumer preferences, and distribution patterns. **Product Type** - Product economics are defined by ingredient familiarity, substantiation burden, formulation complexity and repeat-purchase behavior. Herbal extracts remain commercially important because of established consumer recognition, while vitamins, minerals and natural molecules allow brands to combine familiar nutritional cues with cognitive-wellness positioning. Premium formulations increasingly differentiate through standardized botanicals, phospholipids, citicoline and proprietary multi-ingredient combinations. **Distribution Channel** - Digital channels are the fastest-changing commercial axis as search, social commerce, marketplace discovery and brand D2C reduce geographic barriers. However, pharmacies and specialty retailers retain trust advantages for higher-consideration purchases. Winning strategies increasingly combine compliant online education, subscription or replenishment mechanics, marketplace authentication and selective physical distribution rather than relying on a single route to market. --- ## Regional Analysis # CHAPTER 6 - Regional Analysis Asia Pacific contains materially different demand pools, ranging from Japan's ageing consumer base to India's faster-expanding supplement adoption and China's large regulated health-food ecosystem. Country attractiveness depends on demographics, claims regulation, digital reach and local brand credibility, not market scale alone. ### KPI Summary * Largest Selected Country Market: **Japan** * Fastest Selected Country Growth: **India** * Asia Pacific CAGR (2025-2032): **14.90%** | Country | Market Size (2025, USD Mn, modeled) | CAGR (%) | Population Age 65+ (2024, %) | Primary Health-Supplement Market Access Framework | | --- | --- | --- | --- | --- | | Japan | 900 | 11.0% | 30% | Food health-claim pathways including FFC | | China | 800 | 16.0% | 15% | Health-food registration and filing | | India | 538 | 18.2% | 7% | FSSAI health-supplement and nutraceutical regulation | | Australia | 380 | 10.5% | 18% | TGA listed-medicine framework where applicable | | South Korea | 310 | 13.2% | 19% | MFDS health-functional-food framework | ### Market Position Japan ranks first among the selected country markets in the model, supported by a **30% age-65+ population share in 2024**, the highest among the comparison set. ### Growth Advantage India is modeled as the fastest-growing selected market at **18.2%**, supported by an independent benchmark showing revenue rising from USD 462.9 million in 2024 to USD 1,264.7 million in 2030. ### Competitive Strengths Asia Pacific combines high-ageing demand in Japan, a **206.6 million age-65+ population in China in 2024**, and fast consumer-market expansion in India, creating multiple distinct growth pools. Comprehensive analysis of key factors shaping the market, including growth catalysts, operational challenges, and emerging opportunities across production, distribution, and consumer segments. --- ## Growth Drivers # CHAPTER 7 - Growth Drivers, Challenges & Opportunities Comprehensive analysis of key factors shaping the Asia Pacific Brain Health Supplements Market, including growth catalysts, operational challenges, and emerging opportunities across production, distribution, and consumer segments. ## Growth Drivers ### Healthy-Ageing and Cognitive-Wellness Awareness Cognitive-health salience is increasing as **57 million people (2021, global)** lived with dementia, strengthening consumer attention to lifelong brain health. * Nearly **10 million new dementia cases annually (global)** reinforce public awareness of cognitive decline, expanding interest in wellness categories while requiring brands to avoid unsubstantiated treatment claims. * More than **60% of people with dementia (2021, global)** live in low- and middle-income countries, making affordable wellness positioning strategically relevant across emerging Asian markets. * China had approximately **206.6 million people aged 65+ (2024)**, supporting a structurally large healthy-ageing consumer base for compliant nutrition and wellness products. ### Premium Ingredient and Formulation Innovation Brand investment is moving toward science-positioned ingredients, illustrated by **two new cognition-support launches (2026, Australia/New Zealand)** from Blackmores and Kirin. * Blackmores Cognition Ultra was its **first product focused on cognitive performance (2026, Australia)**, showing established supplement companies allocating innovation resources specifically to cognition. * FANCL has marketed nutritional supplements since the **1990s (Japan)** and built specialist consumer-support infrastructure, illustrating the depth of Japan's supplement ecosystem. * NOW reports distribution in **more than 100 countries**, showing how scaled supplement manufacturers can commercialize formulations through cross-border and distributor-led models. ### Omnichannel Expansion and Cross-Border Brand Access Health brands are widening physical and digital access, including GNC's **first Singapore Watsons store-within-store launch (2025)**. * GNC's Singapore partnership entered Watsons' **largest local store (2025)**, demonstrating how pharmacy and beauty chains can lower customer-acquisition costs for imported supplement brands. * Singapore's voluntary health-supplement notification initiative has operated since **1 August 2022**, giving compliant suppliers an additional transparency mechanism for consumers and channel partners. * Nestlé Health Science reports products across **more than 140 countries**, illustrating the distribution leverage available to diversified nutrition groups entering specialist wellness categories. --- ## Market Challenges ### Scientific Evidence and Claims Boundary WHO's 2026 guidance states that several common supplements are **not recommended for dementia-risk reduction without diagnosed deficiency**, tightening credible positioning boundaries. * WHO estimates that up to **45% of dementia risk (2026 guidance)** relates to modifiable factors, but its recommended interventions emphasize broader lifestyle and medical risk management rather than routine supplementation. * The guidance specifically references vitamins B and E, omega-3 PUFA and multivitamin/mineral products, creating a **defined evidence constraint (2026)** on dementia-prevention messaging. * Brands therefore require substantiation at the ingredient, dose and claim level, increasing clinical, regulatory and legal review expenditure before **each jurisdiction-specific launch**. ### Fragmented Regulatory Market Access Regulatory pathways differ significantly, with India maintaining **multiple regulated functional-food categories** while Japan operates separate health-claim classifications. * India's framework identifies **eight functional-food categories** under the cited 2016 regulations, increasing classification and labelling complexity for multi-category portfolios. * Japan distinguishes **three health-function food systems**, requiring suppliers to align scientific evidence and claims with the applicable regulatory route. * China's health-food framework requires registration for specified categories including certain new ingredients and first-import products, creating **pre-market documentation requirements** for cross-border suppliers. ### Online Counterfeit and Adulteration Risk Singapore removed **more than 7,000 illegal health-product listings (2024)**, illustrating trust and enforcement risks as supplement commerce digitizes. * A coordinated 2024 operation removed **3,336 listings** and generated **1,471 seller warnings**, raising the importance of marketplace authentication and authorized-reseller policies. * During 2025, the regulator reported seizure of **over 1 million illegal health products** and removal of more than 2,300 online listings, maintaining enforcement pressure. * Operation Pangea XVII removed **1,288 illegal listings (2024-2025 period)**, showing that digital channel growth requires continuous seller monitoring rather than one-time compliance. --- ## Market Opportunities ### Evidence-Led Premium Cognitive Formulations The 2026 Blackmores-Kirin launch demonstrates a monetizable path through **patented citicoline-based cognition products** rather than generic disease-prevention messaging. * Premium ingredient partnerships can improve price realization by combining proprietary inputs with recognizable brands, as demonstrated by **Cognizin-containing launches in two APAC markets (2026)**. * Manufacturers with formulation, evidence and regulatory capabilities capture the greatest value because compliant differentiation can reduce reliance on commoditized single-ingredient products across **multiple price tiers**. * Commercialization requires claims to remain within permitted wellness boundaries, especially given WHO's **2026 supplementation guidance** on dementia-risk reduction. ### India-Led Emerging Market Expansion India's published category benchmark rises from **USD 462.9 million in 2024 to USD 1,264.7 million by 2030**, supporting localized investment. * Brand owners and distributors can monetize rising supplement penetration by localizing price points, pack sizes and digital acquisition around a market projected to expand by **more than 2.7 times between 2024 and 2030**. * Domestic and multinational suppliers benefit from an established FSSAI framework covering **health supplements and nutraceuticals**, providing a defined compliance route rather than an unregulated category. * Success depends on compliant labelling, target-consumer declarations and recommended-use communication because draft rules explicitly prescribe **multiple front- and back-of-pack disclosures**. ### Trusted Digital Commerce and Replenishment Models Singapore's voluntary notification system has operated since **August 2022**, illustrating how transparency tools can support trusted digital supplement commerce. * D2C subscriptions and authorized marketplace stores create recurring-revenue opportunities by converting cognitive wellness into **monthly or multi-month replenishment cycles** rather than episodic purchasing. * Brands with validated seller networks benefit as enforcement removes non-compliant alternatives; more than **2,300 online illegal listings were removed in Singapore in 2025**. * What must change is stronger platform authentication, standardized product data and cross-border compliance workflows capable of supporting **multiple national regulatory regimes** without inconsistent claims. --- --- ## Competitive Landscape # CHAPTER 8 - Competitive Landscape Overview Competition combines multinational nutrition groups, established Asia Pacific supplement brands, direct-selling networks and a fragmented tail of local specialists and digital-first SMEs, with differentiation centered on trust, formulation science, channel reach and regulatory execution. * **Key players:** 10 * **New Entrants (last 5 yrs):** - ### Company Profiles (Top 10 Players) | Company Name | Market Share | Headquarters | Founding Year | Core Market Focus | | --- | --- | --- | --- | --- | | Blackmores Limited | - | Sydney, Australia | 1932 | Natural health, cognition support, vitamins and nutritional supplements | | Swisse Wellness (H&H Group) | - | Melbourne, Australia | 1969 | Brain health, memory support, vitamins and wellness supplements | | FANCL Corporation | - | - | 1981 | Nutritional supplements, functional nutrition and healthy-ageing products | | Suntory Wellness Limited | - | - | - | DHA/EPA, sesame science, omega products and healthy-ageing nutrition | | GNC Holdings, LLC | - | Pittsburgh, USA | 1935 | Nootropics, vitamins, cognitive wellness and specialty nutrition retail | | Amway Corporation (Nutrilite) | - | Ada, Michigan, USA | 1959 | Botanical nutrition, vitamins, minerals and direct-selling supplements | | NOW Foods | - | - | - | Dietary supplements, natural ingredients and international distributor networks | | Life Extension | - | Fort Lauderdale, Florida, USA | 1980 | Brain health, healthy ageing and science-positioned supplements | | Nestlé Health Science | - | Switzerland | 2011 | Specialized nutrition, mental performance and consumer health supplements | | Otsuka Pharmaceutical Co., Ltd. (Nature Made) | - | Tokyo, Japan | - | Vitamins, supplements, ginkgo products and evidence-based nutraceuticals | The report provides detailed cross-comparison of key players across 4 performance parameters to identify competitive strengths and weaknesses. ### Top 4 Cross-Comparison KPIs * Cognitive-SKU Breadth * APAC Distribution Reach * Supplement Revenue Growth * R&D Intensity ### Analysis Covered * **Market Share Analysis:** Compares competitive scale while avoiding unsupported player share estimates. * **Cross Comparison Matrix:** Benchmarks product breadth, distribution, growth and innovation investment capabilities. * **SWOT Analysis:** Assesses brand equity, evidence capabilities, compliance risks and whitespace. * **Pricing Strategy Analysis:** Evaluates mass, premium and practitioner-grade positioning across key channels. * **Company Profiles:** Maps corporate footprint, history, portfolio focus and competitive relevance. Company verification references:,. --- --- ## Key Stakeholders # CHAPTER 10 - Key Target Audience Key stakeholders who can leverage from this market analysis for investment, strategy, and operational planning. * **Investors:** CAGR, premiumization, repeat purchase, regulatory risk, exits * **Corporates:** portfolio mix, innovation pipeline, claims, channel economics * **Government:** supplement safety, claims compliance, labelling, digital enforcement * **Operators:** formulation, sourcing, quality assurance, inventory, replenishment * **Financial institutions:** revenue resilience, working capital, brand risk, covenants ### What You'll Gain * Market sizing and trajectory * Regulatory pathway mapping * Segment growth priorities * Competitive landscape shortlist * Channel economics assessment * CEO-grade risk priorities --- --- ## Research Methodology # CHAPTER 11 - Research Methodology ### Phase 1: Approach #### Desk Research * Regional supplement revenue benchmark analysis * Health-claim regulation pathway mapping * Company cognition portfolio verification review * Ageing and cognitive-demand indicator analysis #### Primary Research * Supplement category directors and buyers * Regulatory affairs managers and pharmacists * E-commerce category managers and distributors * Dietitians and preventive-health physicians #### Validation and Triangulation * 348-respondent cross-market validation sample * Supply-demand estimate reconciliation checks * Country benchmark consistency testing framework * Claims-scope and taxonomy validation ### Phase 2: Market Size Estimation #### Top-Down Assessment * Asia Pacific brain-health supplement revenue pool * Breakdown by consumer use-case and channel * Demographic and regulatory demand indicators #### Bottom-Up Modeling * Brand-level cognitive supplement portfolio benchmarks * Pack-equivalent pricing and premium-mix assessment * Unit volume multiplied by realized revenue #### Forecasting and Scenario Analysis * Ageing, digital penetration and premiumization regression * Claims regulation and evidence-risk scenarios * Baseline, optimistic and constrained projections through 2032 ### Phase 3: Primary Research Coverage #### Scope Item / Segments Coverage spans the Asia Pacific brain-health supplement value chain from branded formulation and manufacturing through retail, digital distribution and healthcare-influenced consumer demand. * Branded Supplement Manufacturers * Pharmacies and Specialty Retailers * E-commerce and D2C Channels * Healthcare Practitioners and Consumer Panels #### Sample Size Respondents were structured across commercial, regulatory, channel and demand-side cohorts to provide robust coverage of the Asia Pacific Brain Health Supplements Market. * Branded Supplement Manufacturers - 88 respondents (Category Directors, Regulatory Affairs Managers) * Pharmacies and Specialty Retailers - 74 respondents (Category Buyers, Pharmacists) * E-commerce and D2C Channels - 66 respondents (Marketplace Category Managers, Digital Commerce Managers) * Healthcare Practitioners and Consumer Panels - 120 respondents (Dietitians, Preventive Health Physicians) #### Validation and Triangulation Validation reconciled commercial estimates across respondent cohorts, value-chain positions, country markets and regulatory environments. * Cross-market brand and channel consistency checks * Manufacturer-to-retailer value-chain reconciliation * Operational-versus-strategic respondent comparison * CAGR and revenue-closure arithmetic validation --- ## Frequently Asked Questions # CHAPTER 12 - FAQs #### Q: What was the size of the Asia Pacific Brain Health Supplements Market in 2025? **A:** The Asia Pacific Brain Health Supplements Market was valued at USD 3,791 million in 2025 under the report's broad consumer cognitive-wellness scope. The estimate covers herbal extracts, natural molecules, vitamins and minerals, and multi-ingredient nootropic formulations sold to consumers across Asia Pacific. It excludes prescription medicines and does not treat supplements as medical therapy for dementia. The base-year model is anchored to a published regional value of USD 3,265.6 million in 2024 and reconciled against channel, unit-volume and country-level demand assumptions. **Data used:** USD 3,791 million (2025); USD 3,265.6 million published regional benchmark (2024) **So what:** Investors should treat the category as a sizeable consumer-wellness market whose value depends heavily on product-scope discipline. #### Q: How fast is the Asia Pacific Brain Health Supplements Market expected to grow through 2032? **A:** The market is projected to reach USD 10,024 million by 2032, implying a 14.90% CAGR from the 2025 base. The forecast assumes growth near 16% through 2030 before moderating as the market becomes larger and penetration matures. Growth is supported by healthy-ageing demand, digital replenishment, premium ingredients and localized formulations. The model does not assume that stronger cognitive-health awareness automatically validates therapeutic efficacy; regulatory claims and evidence standards remain explicit constraints on monetization. **Data used:** USD 10,024 million (2032); 14.90% CAGR (2025-2032) **So what:** Growth remains attractive, but quality of revenue will increasingly depend on repeat purchase and compliant premiumization rather than category awareness alone. #### Q: Where will the strongest profit-pool shift occur? **A:** Profit pools are expected to migrate toward differentiated formulations, premium ingredients and digitally replenished portfolios rather than undifferentiated commodity supplements. Brand owners able to substantiate product-specific wellness claims can command better pricing while using D2C and authenticated marketplace channels to retain customer data. The 2026 Blackmores-Kirin cognition launch using Cognizin citicoline illustrates the strategic move toward branded functional ingredients. Practitioner-grade products and premium multi-ingredient formulations should consequently gain disproportionate margin importance relative to basic single-ingredient offerings. **Data used:** Premium Product Share 36.5% (2025 model); 47.0% (2032 model) **So what:** Capital should prioritize formulation IP, substantiation, regulatory capability and high-retention channels rather than simply expanding SKU count. #### Q: What is the most important market risk? **A:** The most important risk is a mismatch between consumer expectations and the scientific evidence permitted for marketing claims. WHO's 2026 dementia-risk-reduction guidance does not recommend vitamins B and E, omega-3 PUFA or multivitamin/mineral supplementation for dementia-risk reduction without diagnosed deficiency. Brands that blur general cognitive wellness with disease prevention can therefore face regulatory, reputational and channel risk. The commercial response is to use narrow, substantiated structure-function or wellness positioning and maintain market-specific evidence dossiers. **Data used:** Up to 45% modifiable dementia-risk contribution cited in 2026 WHO guidance; nearly 10 million new dementia cases annually globally **So what:** Scientific and regulatory affairs capabilities should be treated as revenue-protection functions, not administrative overhead. #### Q: Which Asia Pacific country offers the strongest growth opportunity? **A:** India represents one of the strongest expansion opportunities in the selected country set. An independent public benchmark places India's brain-health supplement revenue at USD 462.9 million in 2024 and USD 1,264.7 million by 2030. Its demographic scale, digital commerce reach and expanding wellness consumption create substantial headroom, although price sensitivity requires localized pack architecture. Japan remains strategically important for ageing-led demand, while China combines scale with more complex health-food registration and filing requirements. **Data used:** India USD 462.9 million (2024); India USD 1,264.7 million (2030) **So what:** Market-entry sequencing should separate high-growth India, premium ageing-led Japan and regulation-intensive China rather than using one regional playbook. #### Q: What is the strongest structural demand driver? **A:** The strongest structural driver is rising attention to cognitive health across both ageing and working-age populations. In 2021, 57 million people globally were living with dementia and nearly 10 million new cases were occurring annually, while Japan's population aged 65 and above reached roughly 30% in 2024. These figures increase societal attention to brain health, but they should be interpreted as awareness drivers rather than proof of supplement efficacy. Productivity, stress and healthy-ageing use cases therefore remain commercially safer than disease-treatment positioning. **Data used:** 57 million people with dementia (2021 global); Japan age 65+ share 30% (2024) **So what:** Product portfolios should target specific wellness jobs-to-be-done while preserving a strict boundary between nutrition and medical claims. #### Q: How should a new entrant compete against established supplement brands? **A:** A new entrant should avoid competing solely on ingredient availability because many vitamins, botanicals and omega products are readily replicated. Advantage should instead come from a narrowly defined consumer problem, defensible formulation, trusted evidence, regulatory readiness and a controlled distribution model. Digital acquisition can accelerate reach, but marketplace enforcement data show material risk from illegal or misleading products. Partnerships with pharmacists, specialist retailers and authenticated platforms can therefore improve credibility while D2C replenishment supports first-party customer data and repeat economics. **Data used:** 3,336 illegal online health-product listings removed in one Singapore operation (2024); 1,471 seller warnings issued **So what:** The winning entry model combines evidence, brand trust and channel governance rather than pursuing maximum online assortment. --- ## Table of Contents # CHAPTER 14 - Table of Contents ### Market Report Structure Comprehensive coverage across three strategic phases - Market Assessment, Go-To-Market Strategy, and Survey - delivering end-to-end insights from market analysis and execution roadmap to customer demand validation. ## Market Assessment Phase Supply-side and competitive intelligence covering market sizing, segmentation, competitive dynamics, regulatory landscape, and future forecasts. ### 1. Executive Summary and Approach ### 2. Asia Pacific Brain Health Supplements Market Overview #### 2.1 Key Insights and Strategic Recommendations #### 2.2 Asia Pacific Brain Health Supplements Market Overview #### 2.3 Definition and Scope #### 2.4 Evolution of Market Ecosystem #### 2.5 Timeline of Key Regulatory Milestones #### 2.6 Value Chain and Stakeholder Mapping #### 2.7 Business Cycle Analysis #### 2.8 Policy and Incentive Landscape ### 3. Asia Pacific Brain Health Supplements Market Analysis #### 3.1 Growth Drivers ##### 3.1.1 Healthy-Ageing and Cognitive-Wellness Awareness ##### 3.1.2 Premium Ingredient and Formulation Innovation ##### 3.1.3 Omnichannel Expansion and Cross-Border Brand Access #### 3.2 Market Challenges ##### 3.2.1 Scientific Evidence and Claims Boundary ##### 3.2.2 Fragmented Regulatory Market Access ##### 3.2.3 Online Counterfeit and Adulteration Risk #### 3.3 Market Opportunities ##### 3.3.1 Evidence-Led Premium Cognitive Formulations ##### 3.3.2 India-Led Emerging Market Expansion ##### 3.3.3 Trusted Digital Commerce and Replenishment Models #### 3.4 Market Trends ##### 3.4.1 Premiumization Through Patented Functional Ingredients ##### 3.4.2 Shift Toward Brand D2C and Marketplace Replenishment ##### 3.4.3 Healthy-Ageing Positioning Beyond Senior Consumers ##### 3.4.4 Greater Claims Substantiation and Product Transparency #### 3.5 Government Regulation ##### 3.5.1 Japan Foods with Function Claims Framework ##### 3.5.2 India Health Supplement and Nutraceutical Regulation ##### 3.5.3 Australia Listed Complementary Medicine Requirements ##### 3.5.4 Singapore Health Supplement Safety and Claims Rules ### 4. SWOT Analysis ### 5. Stakeholder Analysis ### 6. Porter's Five Forces Analysis ### 7. Asia Pacific Brain Health Supplements Market Size #### 7.1 By Value #### 7.2 By Volume #### 7.3 By Average Selling Price ### 8. Asia Pacific Brain Health Supplements Market Segmentation #### 8.1 Product Type ##### 8.1.1 Herbal Extracts ##### 8.1.2 Natural Molecules ##### 8.1.3 Vitamins & Minerals ##### 8.1.4 Multi-Ingredient Nootropic Blends #### 8.2 Price Tier ##### 8.2.1 Mass Market ##### 8.2.2 Mid-Premium ##### 8.2.3 Premium ##### 8.2.4 Clinical/Practitioner Grade #### 8.3 Customer Type ##### 8.3.1 Students & Young Professionals ##### 8.3.2 Working-Age Wellness Consumers ##### 8.3.3 Active Agers 50+ ##### 8.3.4 Caregivers & Family Purchasers #### 8.4 Purchase Occasion ##### 8.4.1 Daily Cognitive Maintenance ##### 8.4.2 Memory & Healthy Ageing ##### 8.4.3 Focus & Productivity ##### 8.4.4 Stress & Mood Support #### 8.5 Distribution Channel ##### 8.5.1 Pharmacies & Drug Stores ##### 8.5.2 Specialty Nutrition Retail ##### 8.5.3 Brand D2C E-commerce ##### 8.5.4 Online Marketplaces ##### 8.5.5 Direct Selling #### 8.6 Packaging Format ##### 8.6.1 Capsules & Tablets ##### 8.6.2 Softgels ##### 8.6.3 Gummies & Chewables ##### 8.6.4 Powders & Sachets ##### 8.6.5 Liquids #### 8.7 Geography ##### 8.7.1 Japan ##### 8.7.2 China ##### 8.7.3 India ##### 8.7.4 Australia & New Zealand ##### 8.7.5 South Korea & Southeast Asia ### 9. Asia Pacific Brain Health Supplements Market Competitive Analysis #### 9.1 Market Share of Key Players (Micro, Small, Medium, Large Enterprises) #### 9.2 Cross Comparison of Key Players ##### 9.2.1 Company Name ##### 9.2.2 Group Size (Large, Medium, or Small as per industry convention) ##### 9.2.3 Cognitive-SKU Breadth ##### 9.2.4 APAC Distribution Reach ##### 9.2.5 Supplement Revenue Growth ##### 9.2.6 R&D Intensity #### 9.3 SWOT Analysis of Top Players #### 9.4 Pricing Analysis #### 9.5 Detailed Profile of Major Companies ##### 9.5.1 Blackmores Limited ##### 9.5.2 Swisse Wellness (H&H Group) ##### 9.5.3 FANCL Corporation ##### 9.5.4 Suntory Wellness Limited ##### 9.5.5 GNC Holdings, LLC ##### 9.5.6 Amway Corporation (Nutrilite) ##### 9.5.7 NOW Foods ##### 9.5.8 Life Extension ##### 9.5.9 Nestlé Health Science ##### 9.5.10 Otsuka Pharmaceutical Co., Ltd. (Nature Made) ### 10. Asia Pacific Brain Health Supplements Market End-User Analysis #### 10.1 Procurement Behavior of Key End-Users ##### 10.1.1 Ingredient and Claim Evaluation ##### 10.1.2 Brand Trust and Quality Signals ##### 10.1.3 Price and Pack-Size Trade-Offs ##### 10.1.4 Channel and Replenishment Preferences #### 10.2 Corporate Spend Patterns ##### 10.2.1 Formulation and Ingredient Investment ##### 10.2.2 Regulatory and Evidence Expenditure ##### 10.2.3 Digital Customer Acquisition Spend ##### 10.2.4 Retail Trade and Distribution Spend #### 10.3 Pain Point Analysis by End-User Category ##### 10.3.1 Evidence Credibility ##### 10.3.2 Product Differentiation ##### 10.3.3 Price Sensitivity ##### 10.3.4 Counterfeit and Seller Trust #### 10.4 User Readiness for Adoption ##### 10.4.1 Healthy-Ageing Consumers ##### 10.4.2 Productivity-Oriented Professionals ##### 10.4.3 Digital-First Supplement Buyers ##### 10.4.4 Practitioner-Influenced Consumers #### 10.5 Post-Deployment ROI and Use Case Expansion ##### 10.5.1 Subscription Replenishment Economics ##### 10.5.2 Cross-Sell Into Healthy Ageing ##### 10.5.3 Premium Ingredient Portfolio Expansion ##### 10.5.4 Geographic Rollout Across APAC ### 11. Asia Pacific Brain Health Supplements Market Future Size #### 11.1 By Value #### 11.2 By Volume #### 11.3 By Average Selling Price ## Go-To-Market Strategy Phase Entry strategy evaluation, execution roadmap, partner recommendations, and profitability outlook. ### 1. Whitespace Analysis and Business Model Canvas #### 1.1 Evidence-Led Cognitive Wellness Whitespace #### 1.2 Healthy-Ageing Portfolio Adjacencies #### 1.3 Premium Ingredient Partnership Models #### 1.4 Digital Replenishment Business Models ### 2. Marketing and Positioning Recommendations #### 2.1 Wellness Claims Positioning #### 2.2 Consumer Education Architecture #### 2.3 Premium Ingredient Storytelling #### 2.4 Market-Specific Regulatory Messaging ### 3. Distribution Plan #### 3.1 Pharmacy Channel Prioritization #### 3.2 Specialty Nutrition Partnerships #### 3.3 Brand D2C Expansion #### 3.4 Authenticated Marketplace Distribution ### 4. Channel and Pricing Gaps #### 4.1 Entry Price Pack Architecture #### 4.2 Mid-Premium Portfolio Gaps #### 4.3 Practitioner-Grade Pricing #### 4.4 Online-Offline Price Governance ### 5. Unmet Demand and Latent Needs #### 5.1 Everyday Focus Support #### 5.2 Healthy Memory Maintenance #### 5.3 Stress-Linked Cognitive Wellness #### 5.4 Transparent Evidence Communication ### 6. Customer Relationship #### 6.1 Replenishment Subscription Programs #### 6.2 Pharmacist-Led Education #### 6.3 Personalized Digital Content #### 6.4 Loyalty and Retention Analytics ### 7. Value Proposition #### 7.1 Evidence-Led Formulation #### 7.2 Trusted Ingredient Sourcing #### 7.3 Compliant Cognitive-Wellness Claims #### 7.4 Convenient Omnichannel Replenishment ### 8. Key Activities #### 8.1 Ingredient Qualification #### 8.2 Clinical Evidence Review #### 8.3 Regulatory Submission Management #### 8.4 Channel Performance Optimization ### 9. Entry Strategy Evaluation #### 9.1 Domestic Market Entry Strategy ##### 9.1.1 Country Prioritization ##### 9.1.2 Regulatory Classification ##### 9.1.3 Local Channel Partnerships ##### 9.1.4 Consumer Acquisition Launch #### 9.2 Export Entry Strategy ##### 9.2.1 Cross-Border Product Registration ##### 9.2.2 Distributor Due Diligence ##### 9.2.3 Localized Claims and Packaging ##### 9.2.4 Marketplace Brand Protection ### 10. Entry Mode Assessment #### 10.1 Direct-to-Consumer Entry #### 10.2 Distributor-Led Entry #### 10.3 Pharmacy Partnership Entry #### 10.4 Strategic Ingredient Collaboration ### 11. Capital and Timeline Estimation #### 11.1 Regulatory Setup Investment #### 11.2 Formulation and Evidence Investment #### 11.3 Inventory and Working Capital #### 11.4 Customer Acquisition Ramp-Up ### 12. Control vs Risk Trade-Off #### 12.1 Direct Brand Control #### 12.2 Distributor Execution Risk #### 12.3 Marketplace Compliance Risk #### 12.4 Claims and Reputation Risk ### 13. Profitability Outlook #### 13.1 Premium-Mix Margin Expansion #### 13.2 Subscription Retention Economics #### 13.3 Channel Margin Optimization #### 13.4 Regulatory Cost Absorption ### 14. Potential Partner List #### 14.1 Pharmacy Chains #### 14.2 Specialty Nutrition Retailers #### 14.3 Digital Marketplaces #### 14.4 Functional Ingredient Suppliers ### 15. Execution Roadmap #### 15.1 Phased Plan for Market Entry ##### 15.1.1 Market Setup ##### 15.1.2 Market Entry ##### 15.1.3 Growth Acceleration ##### 15.1.4 Scale and Stabilize #### 15.2 Key Activities and Milestones ##### 15.2.1 Claims and Regulatory Clearance ##### 15.2.2 Channel Partner Activation ##### 15.2.3 Digital Acquisition Optimization ##### 15.2.4 Portfolio and Geography Expansion ## Survey Phase Demand-side primary research conducted through structured interviews and online surveys with end users across priority metros and Tier 2/3 cities to capture consumption behavior, unmet needs, and purchase drivers. ### 1. Research Design and Sample Architecture #### 1.1 Research Objectives and Scope #### 1.2 Sample Size Rationale and Representation #### 1.3 Customer Cohort Definitions #### 1.4 Geographic Coverage - Priority Metros and Tier 2/3 Cities ### 2. Data Collection Methodology #### 2.1 Structured Interview Framework (50 In-Depth Interviews) ##### 2.1.1 Interview Guide and Question Design ##### 2.1.2 Respondent Recruitment and Screening Criteria ##### 2.1.3 Interview Execution and Quality Control ##### 2.1.4 Qualitative Coding and Insight Extraction #### 2.2 Online Survey Design (200 Structured Surveys) ##### 2.2.1 Survey Instrument and Attribute Coverage ##### 2.2.2 Platform Selection and Distribution Channels ##### 2.2.3 Response Validation and Data Cleaning ##### 2.2.4 Statistical Significance and Margin of Error ### 3. Customer Cohort Profiles #### 3.1 Cohort 1 - Active Agers 50+ ##### 3.1.1 Cohort Definition and Size ##### 3.1.2 Key Demand Attributes ##### 3.1.3 Purchase Decision Drivers ##### 3.1.4 Represented Sample Size and Metro Distribution #### 3.2 Cohort 2 - Working-Age Wellness Consumers ##### 3.2.1 Cohort Definition and Size ##### 3.2.2 Key Demand Attributes ##### 3.2.3 Purchase Decision Drivers ##### 3.2.4 Represented Sample Size and City Distribution #### 3.3 Cohort 3 - Students & Young Professionals ##### 3.3.1 Cohort Definition and Size ##### 3.3.2 Key Demand Attributes ##### 3.3.3 Purchase Decision Drivers ##### 3.3.4 Represented Sample Size and Tier 2/3 City Distribution #### 3.4 Cohort 4 - Caregivers & Family Purchasers ##### 3.4.1 Cohort Definition and Size ##### 3.4.2 Key Demand Attributes ##### 3.4.3 Procurement and Trust Drivers ##### 3.4.4 Represented Sample Size and Regional Distribution ### 4. Demand Attributes Analysis #### 4.1 Macroeconomic and Sectoral Growth Influences on Demand ##### 4.1.1 Healthy-Ageing and Demographic Linkages ##### 4.1.2 Digital Commerce Expansion Impact ##### 4.1.3 Wellness Spending and Purchase Timing ##### 4.1.4 Import Dependency on Brain Health Supplements #### 4.2 End-User Behavior and Consumption Patterns ##### 4.2.1 Frequency and Volume of Purchases ##### 4.2.2 Routine and Occasion-Based Supplementation ##### 4.2.3 Brand Loyalty vs Price Sensitivity Trade-Off ##### 4.2.4 Switching Triggers and Retention Factors #### 4.3 Pricing Perception and Value Assessment ##### 4.3.1 Willingness to Pay Across Cohorts ##### 4.3.2 Price Benchmarking Against Standard Supplements ##### 4.3.3 Country Pricing Disparities ##### 4.3.4 Monthly Regimen Cost Perception #### 4.4 Quality, Safety, and Compliance Expectations ##### 4.4.1 Ingredient Quality and Certification Requirements ##### 4.4.2 Health-Claim Compliance Awareness ##### 4.4.3 Perception of Domestic vs Imported Offerings ##### 4.4.4 Pharmacist and Practitioner Trust Expectations #### 4.5 Cultural, Regional, and Contextual Demand Factors ##### 4.5.1 Country Demand Hotspots ##### 4.5.2 Traditional Wellness Influence ##### 4.5.3 Peer and Practitioner Influence ##### 4.5.4 Digital Adoption and E-Commerce Readiness #### 4.6 Marketing, Awareness, and Channel Influence ##### 4.6.1 Health Education and Wellness Events ##### 4.6.2 Role of Digital Marketing and Online Platforms ##### 4.6.3 Pharmacy and Retailer Influence on Purchase ##### 4.6.4 Ingredient Supplier Partnership Impact ### 5. Unmet Needs and Latent Demand Signals #### 5.1 Identified Gaps Between Evidence and User Expectations #### 5.2 Latent Demand in Underpenetrated Consumer Segments #### 5.3 Willingness to Adopt New Formats or Ingredients #### 5.4 Pain Points Surfaced Across Cohorts ### 6. Key Findings and Strategic Implications #### 6.1 Top Demand Drivers Ranked by Cohort #### 6.2 Barriers to Purchase and Adoption #### 6.3 High-Priority Customer Segments for Market Entry #### 6.4 Recommendations for Product, Pricing, and Channel Strategy ### Disclaimer ### Contact Us